{"title":"基于方案的2019冠状病毒病管理清单","authors":"Behjat Taheri, Amirhossein Akhavan Sigari, Leili Kamali, Ahmad Zarei, Firouzeh Moeinzadeh, Marzieh Salimi Bani, Saeed Abbasi","doi":"10.4103/jrms.jrms_169_22","DOIUrl":null,"url":null,"abstract":"| 2023 | 1 been dedicated to corticosteroid treatment. Usually, 8 mg of dexamethasone is given daily intravenously for up to 10 days. Higher doses can cause adverse events such as osteoporosis and elevated blood glucose levels[2] 4. Cytokine storm: This section is divided into two sections: diagnostic criteria and treatment. When cytokine storm clinical data are met, the syndrome is confirmed with laboratory testing. Management is l imited to dexamethasone and methylprednisolone in different doses. Tocilizumab is also mentioned at the end of the checklist under the subheading “miscellaneous treatments”[3] 5. Anticoagulation and gastrointestinal care: Based on national protocols, we provide these two sections for prophylactic measures. Prophylactic anticoagulation based on patient body mass index and hospitalization status is provided. Acid blocking agents are also given based on patient risk factors and hospitalization status[4] 6. Antibiotics and antiviral therapy: Based on designated criteria such as refractory fever, decreased consciousness, and oxygen saturation, as well as the physician’s expert opinion, antiviral therapy (remdesivir) and antibiotic treatment are initiated.","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"28 ","pages":"9"},"PeriodicalIF":1.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/12/85/JRMS-28-9.PMC10039103.pdf","citationCount":"0","resultStr":"{\"title\":\"A protocol-based checklist for the management of coronavirus disease 2019.\",\"authors\":\"Behjat Taheri, Amirhossein Akhavan Sigari, Leili Kamali, Ahmad Zarei, Firouzeh Moeinzadeh, Marzieh Salimi Bani, Saeed Abbasi\",\"doi\":\"10.4103/jrms.jrms_169_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"| 2023 | 1 been dedicated to corticosteroid treatment. Usually, 8 mg of dexamethasone is given daily intravenously for up to 10 days. Higher doses can cause adverse events such as osteoporosis and elevated blood glucose levels[2] 4. Cytokine storm: This section is divided into two sections: diagnostic criteria and treatment. When cytokine storm clinical data are met, the syndrome is confirmed with laboratory testing. Management is l imited to dexamethasone and methylprednisolone in different doses. Tocilizumab is also mentioned at the end of the checklist under the subheading “miscellaneous treatments”[3] 5. Anticoagulation and gastrointestinal care: Based on national protocols, we provide these two sections for prophylactic measures. Prophylactic anticoagulation based on patient body mass index and hospitalization status is provided. Acid blocking agents are also given based on patient risk factors and hospitalization status[4] 6. Antibiotics and antiviral therapy: Based on designated criteria such as refractory fever, decreased consciousness, and oxygen saturation, as well as the physician’s expert opinion, antiviral therapy (remdesivir) and antibiotic treatment are initiated.\",\"PeriodicalId\":50062,\"journal\":{\"name\":\"Journal of Research in Medical Sciences\",\"volume\":\"28 \",\"pages\":\"9\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/12/85/JRMS-28-9.PMC10039103.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Research in Medical Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4103/jrms.jrms_169_22\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Research in Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/jrms.jrms_169_22","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
A protocol-based checklist for the management of coronavirus disease 2019.
| 2023 | 1 been dedicated to corticosteroid treatment. Usually, 8 mg of dexamethasone is given daily intravenously for up to 10 days. Higher doses can cause adverse events such as osteoporosis and elevated blood glucose levels[2] 4. Cytokine storm: This section is divided into two sections: diagnostic criteria and treatment. When cytokine storm clinical data are met, the syndrome is confirmed with laboratory testing. Management is l imited to dexamethasone and methylprednisolone in different doses. Tocilizumab is also mentioned at the end of the checklist under the subheading “miscellaneous treatments”[3] 5. Anticoagulation and gastrointestinal care: Based on national protocols, we provide these two sections for prophylactic measures. Prophylactic anticoagulation based on patient body mass index and hospitalization status is provided. Acid blocking agents are also given based on patient risk factors and hospitalization status[4] 6. Antibiotics and antiviral therapy: Based on designated criteria such as refractory fever, decreased consciousness, and oxygen saturation, as well as the physician’s expert opinion, antiviral therapy (remdesivir) and antibiotic treatment are initiated.
期刊介绍:
Journal of Research in Medical Sciences, a publication of Isfahan University of Medical Sciences, is a peer-reviewed online continuous journal with print on demand compilation of issues published. The journal’s full text is available online at http://www.jmsjournal.net. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository.